Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
Li Luo,1,* Ting Du,1,* Jiumeng Zhang,1 Wei Zhao,2 Hao Cheng,1 Yuping Yang,1 Yujiao Wu,1 Chunmei Wang,1 Ke Men,1 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, 2Department of Thoracic Onco...
Main Authors: | Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-02-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/efficient-inhibition-of-ovarian-cancer-by-degradable-nanoparticle-deli-peer-reviewed-article-IJN |
Similar Items
-
Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
by: Luo L, et al.
Published: (2020-12-01) -
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
by: Beata Gąsowska-Bajger, et al.
Published: (2021-02-01) -
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
by: Felisiak-Golabek Anna, et al.
Published: (2011-11-01) -
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
by: Silvia Martini, et al.
Published: (2021-05-01) -
Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer
by: Diana Trnski, et al.
Published: (2019-02-01)